Back to today’s briefing

Story perspectives

New FDA-Approved Lenses Could Cut Myopia Progression by 70%

12/2/2025

28 6

Summary

Story summary

The Essilor Stellest lenses, FDA-approved, aim to slow myopia progression in children aged 6 to 12, amid a 30%–40% prevalence anticipated by high school graduation.
They reportedly reduce myopia progression by about 70% after two years.
The lenses use concentric rings to refocus light, potentially preventing later eye issues.
They are now available in the United States, with a $450 price and anticipated insurance coverage.

1 of 1

Story summary

The Essilor Stellest lenses, FDA-approved, aim to slow myopia progression in children aged 6 to 12, amid a 30%–40% prevalence anticipated by high school graduation.
They reportedly reduce myopia progression by about 70% after two years.
The lenses use concentric rings to refocus light, potentially preventing later eye issues.
They are now available in the United States, with a $450 price and anticipated insurance coverage.